Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

New Standardized Radiopharmaceutical Dose Estimates

Michael Stabin and Jeffry Siegel
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 108;
Michael Stabin
1Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffry Siegel
2Nuclear Physics Enterprises, Marlton, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

108

Objectives The RAdiation Dose Assessment Resource (RADAR) Task Force of the SNMMI has developed a complete set of standardized anthropomorphic phantoms for adults, children, and pregnant women. These phantoms are implemented in the OLINDA/EXM version 2 computer code for internal dosimetry calculations.

Methods We have entered biokinetic data from the various publications of the ICRP Task Group on Radiopharmaceuticals for dozens of radiopharmaceuticals in routine use in nuclear medicine into the OLINDA/EXM 2 code, and calculated organ doses and effective doses for these agents.

Results Doses for most organs did not change significantly, even though specific absorbed fractions for some organs are higher than for previous phantoms, due to the more realistic modeling of organ shapes and proximity. One exception is the pancreas, as the ICRP recommended mass changed by about 40%. As pancreas is not very important to effective dose calculations, however, effective doses for most radiopharmaceuticals did not change by more than 20%.

Conclusions This radiopharmaceutical dosimetry compendium will serve the nuclear medicine community well for many years to come, and places dose estimates together in one publication, so that users do not have to search through multiple ICRP publications to find the most current dosimetry, Users can easily incorporate this information into their daily practice; we hope to make this available online. In addition, doses for many new organs (e.g. eyes, esophagus, prostate gland) that were not previously available are provided and whenever significant new data become available they can be easily incorporated into this compendium.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
New Standardized Radiopharmaceutical Dose Estimates
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
New Standardized Radiopharmaceutical Dose Estimates
Michael Stabin, Jeffry Siegel
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 108;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
New Standardized Radiopharmaceutical Dose Estimates
Michael Stabin, Jeffry Siegel
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 108;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Evaluation of Methods to Decrease Formation of a Higher Molecular Weight Species When211At-Labeling of Antibody-B10 Conjugates Using Chloramine-T as Oxidant
  • Interaction of Striatal Dopaminergic and Cholinergic Activity in Parkinson Disease: A Multimodal Imaging Study Based on 11C-DTBZ and 18F- FEOBV PET Combined with Diffusion Tensor Imaging
  • Improved Synthesis and Preclinical Evaluation of [18F]FNP-59: a Radiotracer for Imaging Cholesterol Trafficking
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Dosimetry

  • Self-calibration methods for voxel-based dosimetry using 90Y Bremsstrahlung SPECT/CT imaging following selective internal radiation therapy (SIRT) of liver tumors
  • Within-patient variability of18F-FDG uptake in normal tissues
  • Preliminary Human Dosimetry Studies of [11C]-CS1P1, a Novel PET Tracer for Targeting Sphingosine-1-Phosphate Receptor 1 (S1P1)
Show more Dosimetry

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire